Pulse Biosciences Inc
6L8
Company Profile
Business description
Pulse Biosciences Inc is a novel bioelectric medicine company committed to health innovation using its patented Nano-Pulse Stimulation technology, a revolutionary energy modality that delivers nanosecond-duration pulses of electrical energy, each less than a millionth of a second long, to non-thermally clear targeted cells while sparing adjacent noncellular tissue. NPS technology, also referred to as Nanosecond Pulsed-Field Ablation or nsPFA technology when used to ablate cellular tissue, can be used to treat a variety of medical conditions for which an optimal solution remains unfulfilled.
Contact
601 Brickell Key Drive
Suite 1080
MiamiFL33131
USAT: +1 510 906-4600
Sector
Healthcare
Stock type
Defensive
Industry
Medical Instruments & Supplies
Fiscal Year End
31 December 2025
Employees
75
Stocks News & Analysis
Morningstar Investment Ideas
Markets
Index | Last price | Change | % Change |
---|---|---|---|
All Ordinaries | 8,688.00 | 35.50 | -0.41% |
CAC 40 | 7,537.57 | 52.09 | -0.69% |
DAX 40 | 23,269.01 | 81.54 | -0.35% |
Dow JONES (US) | 42,455.29 | 248.47 | 0.59% |
FTSE 100 | 8,758.04 | 16.61 | -0.19% |
HKSE | 23,689.13 | 158.65 | 0.67% |
NASDAQ | 19,606.13 | 158.72 | 0.82% |
Nikkei 225 | 38,354.09 | 49.14 | -0.13% |
NZX 50 Index | 12,532.65 | 36.40 | -0.29% |
S&P 500 | 6,008.00 | 40.16 | 0.67% |
S&P/ASX 200 | 8,474.90 | 30.60 | -0.36% |
SSE Composite Index | 3,381.58 | 21.69 | 0.65% |